Citadel Advisors’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,600
| Closed | -$138K | – | 12346 |
|
|
2025
Q1 | $138K | Buy |
18,600
+10,100
| +119% | +$77.6K | ﹤0.01% | 10995 |
|
|
2024
Q4 | $51K | Sell |
8,500
-21,000
| -71% | -$116K | ﹤0.01% | 12371 |
|
|
2024
Q3 | $151K | Buy |
29,500
+14,000
| +90% | +$61K | ﹤0.01% | 10558 |
|
|
2024
Q2 | $56.1K | Buy |
15,500
+5,100
| +49% | +$16.2K | ﹤0.01% | 11632 |
|
|
2024
Q1 | $33.4K | Sell |
10,400
-2,400
| -19% | -$9.29K | ﹤0.01% | 12588 |
|
|
2023
Q4 | $62.7K | Buy |
12,800
+2,900
| +29% | +$13.2K | ﹤0.01% | 11534 |
|
|
2023
Q3 | $54K | Sell |
9,900
-4,000
| -29% | -$26.4K | ﹤0.01% | 11675 |
|
|
2023
Q2 | $93.3K | Buy |
13,900
+3,600
| +35% | +$26.8K | ﹤0.01% | 11040 |
|
|
2023
Q1 | $90.9K | Sell |
10,300
-5,500
| -35% | -$48.5K | ﹤0.01% | 11400 |
|
|
2022
Q4 | $121K | Sell |
15,800
-19,200
| -55% | -$149K | ﹤0.01% | 10948 |
|
|
2022
Q3 | $249K | Sell |
35,000
-7,100
| -17% | -$66.9K | ﹤0.01% | 9970 |
|
|
2022
Q2 | $341K | Sell |
42,100
-28,300
| -40% | -$249K | ﹤0.01% | 9516 |
|
|
2022
Q1 | $977K | Buy |
70,400
+50,000
| +245% | +$786K | ﹤0.01% | 7746 |
|
|
2021
Q4 | $572K | Sell |
20,400
-60,600
| -75% | -$1.86M | ﹤0.01% | 9366 |
|
|
2021
Q3 | $2.75M | Sell |
81,000
-8,300
| -9% | -$300K | ﹤0.01% | 5566 |
|
|
2021
Q2 | $3.65M | Sell |
89,300
-118,700
| -57% | -$4.61M | ﹤0.01% | 5146 |
|
|
2021
Q1 | $8.37M | Buy |
208,000
+166,700
| +404% | +$9.02M | 0.01% | 3249 |
|
|
2020
Q4 | $2.44M | Buy |
41,300
+20,900
| +102% | +$1.08M | ﹤0.01% | 4940 |
|
|
2020
Q3 | $992K | Buy |
20,400
+1,200
| +6% | +$50.4K | ﹤0.01% | 6045 |
|
|
2020
Q2 | $929K | Buy |
+19,200
| New | +$700K | ﹤0.01% | 5974 |
|
|
2020
Q1 | – | Sell |
-13,100
| Closed | -$392K | – | 9526 |
|
|
2019
Q4 | $392K | Buy |
+13,100
| New | +$376K | ﹤0.01% | 7180 |
|
Other funds holding ADPT
VCM
VPM
